Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 98


Metastasis risk prediction model in osteosarcoma using metabolic imaging phenotypes: A multivariable radiomics model.

Sheen H, Kim W, Byun BH, Kong CB, Song WS, Cho WH, Lim I, Lim SM, Woo SK.

PLoS One. 2019 Nov 25;14(11):e0225242. doi: 10.1371/journal.pone.0225242. eCollection 2019.


Combination Radioimmunotherapy Strategies for Solid Tumors.

Zaheer J, Kim H, Lee YJ, Kim JS, Lim SM.

Int J Mol Sci. 2019 Nov 8;20(22). pii: E5579. doi: 10.3390/ijms20225579. Review.


Comparisons of 131I-rituximab treatment responses in patients with aggressive lymphoma and indolent lymphoma.

Lee I, Byun BH, Lim I, Kim BI, Choi CW, Kim KM, Shin DY, Kang HJ, Lim SM.

Ann Nucl Med. 2019 Dec;33(12):881-890. doi: 10.1007/s12149-019-01401-5. Epub 2019 Sep 30.


Comparison between Fractionated Dose and Single Dose of Cu-64 Trastuzumab Therapy in the NCI-N87 Gastric Cancer Mouse Model.

Zaheer J, Kim H, Lee YJ, Lim SM, Kim JS.

Int J Mol Sci. 2019 Sep 23;20(19). pii: E4708. doi: 10.3390/ijms20194708.


Measurement of Tumor Pressure and Strategies of Imaging Tumor Pressure for Radioimmunotherapy.

Kim HG, Yu AR, Lee JJ, Lee YJ, Lim SM, Kim JS.

Nucl Med Mol Imaging. 2019 Aug;53(4):235-241. doi: 10.1007/s13139-019-00598-7. Epub 2019 Jun 13. Review.


Prediction of Chemotherapy Response of Osteosarcoma Using Baseline 18F-FDG Textural Features Machine Learning Approaches with PCA.

Jeong SY, Kim W, Byun BH, Kong CB, Song WS, Lim I, Lim SM, Woo SK.

Contrast Media Mol Imaging. 2019 Jul 24;2019:3515080. doi: 10.1155/2019/3515080. eCollection 2019.


Comparative analyses of plasma amyloid-β levels in heterogeneous and monomerized states by interdigitated microelectrode sensor system.

Kim Y, Yoo YK, Kim HY, Roh JH, Kim J, Baek S, Lee JC, Kim HJ, Chae MS, Jeong D, Park D, Lee S, Jang H, Kim K, Lee JH, Byun BH, Park SY, Ha JH, Lee KC, Cho WW, Kim JS, Koh JY, Lim SM, Hwang KS.

Sci Adv. 2019 Apr 17;5(4):eaav1388. doi: 10.1126/sciadv.aav1388. eCollection 2019 Apr.


Genetic analysis of a novel antioxidant multi-target iron chelator, M30 protecting against chemotherapy-induced alopecia in mice.

Lim YC, Kim H, Lim SM, Kim JS.

BMC Cancer. 2019 Feb 13;19(1):149. doi: 10.1186/s12885-019-5323-z.


Trastuzumab Induced Chemobrain, Atorvastatin Rescued Chemobrain with Enhanced Anticancer Effect and without Hair Loss-Side Effect.

Lee S, Lee HJ, Kang H, Kim EH, Lim YC, Park H, Lim SM, Lee YJ, Kim JM, Kim JS.

J Clin Med. 2019 Feb 11;8(2). pii: E234. doi: 10.3390/jcm8020234.


Dielectrophoresis-based filtration effect and detection of amyloid beta in plasma for Alzheimer's disease diagnosis.

Kim HJ, Park D, Baek SY, Yang SH, Kim Y, Lim SM, Kim J, Hwang KS.

Biosens Bioelectron. 2019 Mar 1;128:166-175. doi: 10.1016/j.bios.2018.12.046. Epub 2019 Jan 2.


An enhanced treatment effect can be expected from a higher serum thyroglobulin level after radioactive iodine therapy.

Choi JH, Lim I, Lee I, Byun BH, Kim BI, Choi CW, Lim SM.

Ann Nucl Med. 2019 Feb;33(2):128-134. doi: 10.1007/s12149-018-1313-5. Epub 2018 Oct 31.


Evaluation of Hepatoprotective Effect of Curcumin on Liver Cirrhosis Using a Combination of Biochemical Analysis and Magnetic Resonance-Based Electrical Conductivity Imaging.

Kyung EJ, Kim HB, Hwang ES, Lee S, Choi BK, Kim JW, Kim HJ, Lim SM, Kwon OI, Woo EJ.

Mediators Inflamm. 2018 May 17;2018:5491797. doi: 10.1155/2018/5491797. eCollection 2018.


Prediction of tumor differentiation using sequential PET/CT and MRI in patients with breast cancer.

Choi JH, Lim I, Noh WC, Kim HA, Seong MK, Jang S, Seol H, Moon H, Byun BH, Kim BI, Choi CW, Lim SM.

Ann Nucl Med. 2018 Jul;32(6):389-397. doi: 10.1007/s12149-018-1259-7. Epub 2018 May 23.


Feasibility of myocardial PET imaging using a benzylguanidine analog: meta-(3-[18F]fluoropropyl)benzylguanidine ([18F]mFPBG).

Woo SK, Moon BS, Kim BS, Kim MH, Lee YJ, Jung JH, Lee KC, Seo Y, Kim W, Lim SM, Lee BC, Kim SE.

Nucl Med Biol. 2018 Jun;61:63-70. doi: 10.1016/j.nucmedbio.2018.04.005. Epub 2018 May 3.


Early Detection of Aβ Deposition in the 5xFAD Mouse by Amyloid PET.

Oh SJ, Lee HJ, Kang KJ, Han SJ, Lee YJ, Lee KC, Lim SM, Chi DY, Kim KM, Park JA, Choi JY.

Contrast Media Mol Imaging. 2018 Feb 28;2018:5272014. doi: 10.1155/2018/5272014. eCollection 2018.


The Predictive Values of Lesion Size, F-18 FDG Avidity and I-131 Avidity for the Clinical Outcome of I-131 Treatment in Patients with Metastatic Differentiated Thyroid Carcinoma Only in the Lung.

Choi JH, Byun BH, Lim I, Moon H, Park J, Chang KJ, Kim BI, Choi CW, Lim SM.

Nucl Med Mol Imaging. 2018 Apr;52(2):135-143. doi: 10.1007/s13139-017-0502-9. Epub 2017 Nov 7.


Head-to-head comparison of 18 F-FP-CIT and 123 I-FP-CIT for dopamine transporter imaging in patients with Parkinson's disease: A preliminary study.

Lee I, Kim JS, Park JY, Byun BH, Park SY, Choi JH, Moon H, Kim JY, Lee KC, Chi DY, Kim KM, Lim I, Kang JH, Ahn SH, Kim BI, Ha JH, Lim SM.

Synapse. 2018 Jul;72(7):e22032. doi: 10.1002/syn.22032. Epub 2018 Mar 9.


Preliminary 19F-MRS Study of Tumor Cell Proliferation with 3'-deoxy-3'-fluorothymidine and Its Metabolite (FLT-MP).

Ko IO, Jung KH, Kim MH, Kang KJ, Lee KC, Kim KM, Noh I, Lee YJ, Lim SM, Kim JY, Park JA.

Contrast Media Mol Imaging. 2017 Sep 26;2017:3981358. doi: 10.1155/2017/3981358. eCollection 2017.


Head-to-head comparison of 11C-PiB and 18F-FC119S for Aβ imaging in healthy subjects, mild cognitive impairment patients, and Alzheimer's disease patients.

Byun BH, Kim BI, Park SY, Ko IO, Lee KC, Kim KM, Kim YK, Lee JY, Bu SH, Kim JH, Chi DY, Ha JH, Lim SM.

Medicine (Baltimore). 2017 Mar;96(12):e6441. doi: 10.1097/MD.0000000000006441.

Supplemental Content

Loading ...
Support Center